0001209191-15-047677.txt : 20150528 0001209191-15-047677.hdr.sgml : 20150528 20150528183512 ACCESSION NUMBER: 0001209191-15-047677 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20150526 FILED AS OF DATE: 20150528 DATE AS OF CHANGE: 20150528 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: PHARMACYCLICS INC CENTRAL INDEX KEY: 0000949699 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 943148201 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: PHARMACYCLICS INC STREET 2: 995 E ARQUES AVE CITY: SUNNYVALE STATE: CA ZIP: 94085-4521 BUSINESS PHONE: 408 774 0330 MAIL ADDRESS: STREET 1: PHARMACYCLICS INC STREET 2: 995 E ARQUES AVE CITY: SUNNYVALE STATE: CA ZIP: 94085-4521 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Soni Manmeet Singh CENTRAL INDEX KEY: 0001569769 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-26658 FILM NUMBER: 15896736 MAIL ADDRESS: STREET 1: C/O PHARMACYCLICS, INC. STREET 2: 995 EAST ARQUES AVE CITY: SUNNYVALE STATE: CA ZIP: 94085 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2015-05-26 0 0000949699 PHARMACYCLICS INC PCYC 0001569769 Soni Manmeet Singh C/O PHARMACYCLICS, INC. 995 EAST ARQUES AVE SUNNYVALE CA 94085 0 1 0 0 Chief Financial Officer Common Stock 2015-05-26 4 D 0 54000 261.25 D 873 D Common Stock 2015-05-26 4 U 0 873 261.25 D 0 D Common Stock (Right to Buy) 61.60 2015-05-26 4 D 0 11152 D 2022-10-26 Common Stock 11152 0 D Common Stock (Right to Buy) 70.37 2015-05-26 4 D 0 18750 D 2023-02-12 Common Stock 18750 0 D Common Stock (Right to Buy) 106.75 2015-05-26 4 D 0 15000 D 2023-08-16 Common Stock 15000 0 D Common Stock (Right to Buy) 138.66 2015-05-26 4 D 0 8000 D 2024-02-28 Common Stock 8000 0 D Common Stock (Right to Buy) 102.22 2015-05-26 4 D 0 40000 D 2024-04-02 Common Stock 4000 0 D Represents shares issuable pursuant to a Restricted Stock Unit Award that was cancelled in exchange for a cash payment, subject to applicable withholding taxes and pursuant to the procedures terms set forth in the Agreement and Plan of Reorganization (the "Merger Agreement") dated March 4, 2015, by and between the Issuer, AbbVie Inc., a Delaware corporation ("AbbVie"), Oxford Amherst Corporation, a Delaware corporation and a direct wholly owned subsidiary of AbbVie and Oxford Amherst LLC, a Delaware limited liability company and a direct wholly owned subsidiary of AbbVie. Includes 262 shares acquired under the Pharmacyclics, Inc. Employee Stock Purchase Plan on April 30, 2015. Price reflects aggregate per share consideration paid pursuant to the Tender Offer. This option was cancelled pursuant to the terms of the Merger Agreement in exchange for a cash payment equal to the number of shares subject to the option multiplied by the difference between $261.25 and the exercise price of the option, subject to applicable withholding taxes and pursuant to the procedures set forth in the Merger Agreement. /s/ Manmeet S. Soni 2015-05-27